Compounds > 3,3,5,5-tetramethyl-1-pyrroline n-oxide
Page last updated: 2024-09-04

3,3,5,5-tetramethyl-1-pyrroline n-oxide and Cancer of Liver

3,3,5,5-tetramethyl-1-pyrroline n-oxide has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, Z; Ye, H; Zhang, C1

Other Studies

1 other study(ies) available for 3,3,5,5-tetramethyl-1-pyrroline n-oxide and Cancer of Liver

ArticleYear
LncRNA TMPO-AS1 promotes hepatocellular carcinoma progression via activating PI3K-AKT pathway.
    Minerva gastroenterology, 2022, Volume: 68, Issue:3

    Topics: Carcinoma, Hepatocellular; Cyclic N-Oxides; Humans; Liver Neoplasms; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Long Noncoding; Thymopoietins

2022